Delivery Order SPE2DB24D2208-SPE2DB25FHHRU

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $2,757.91. The contract is a firm fixed price, non-set-aside, delivery order contract with a performance period ending on June 16, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,033.17, is for the delivery of an ADVAIR HFA 115-21 MCG INHALER 12GM medication. The contract has an ultimate completion date of May 22, 2024 and is a firm fixed-price delivery order. The contract is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a prescription medication. The fixed-price contract has a ceiling value of $2,695.14 and a period of performance extending through May 20, 2025. The contract is not set aside for any specific business designation. Amerisourcebergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $2,605.55 and a period of performance through July 9, 2024. The contract is a Firm Fixed Price vehicle, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a ceiling value of $6,389.98 and a completion date of January 23, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,204.80 firm-fixed-price contract is for the supply of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract has a completion date of November 17, 2022 and was awarded on November 16, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,525.66, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product. The contract has an ultimate completion date of March 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,702.92 firm fixed-price contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a type of prescription medication. The contract has an ultimate completion date of June 12, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADVAIR HFA 230-21 MCG INHALER 12GM, a medical product, with a ceiling value of $3,152.10 and an ultimate completion date of April 9, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $11,462.32 and is for the provision of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product. The contract is a Firm Fixed Price type and has a completion date of May 29, 2024. There is no set-aside designation for this award. Amerisourcebergen Drug Corp also holds a...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB25FHHRU
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADVAIR HFA 115-21 MCG INHALER 12GM, a pharmaceutical product, with a total ceiling value of $2,897.12 and a completion date of May 23, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp is a for-profit organization that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026.

Generated 8/21/25, 10:03 AM